These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS
186 results:

  • 1. Cafestol inhibits colon cancer cell proliferation and tumor growth in xenograft mice by activating lkb1/AMPK/ULK1-dependent autophagy.
    Feng Y; Yang J; Wang Y; Wang X; Ma Q; Li Y; Zhang X; Wang S; Zhang Q; Mi F; Wang Y; Zhong D; Yin J
    J Nutr Biochem; 2024 Jul; 129():109623. PubMed ID: 38492819
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The deubiquitinase USP10 mediates crosstalk between the lkb1/AMPK axis and Wnt/β-catenin signaling in cancer.
    Wang Y; Liu J; Zheng S; Cao L; Li Y; Sheng R
    FEBS Lett; 2023 Dec; 597(24):3061-3071. PubMed ID: 37873736
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation.
    Yang SR; Gedvilaite E; Ptashkin R; Chang J; Ziegler J; Mata DA; Villafania LB; Nafa K; Hechtman JF; Benayed R; Zehir A; Benhamida J; Arcila ME; Mandelker D; Rudin CM; Paik PK; Drilon A; Schoenfeld AJ; Ladanyi M
    J Thorac Oncol; 2024 Mar; 19(3):409-424. PubMed ID: 37838086
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Familial intestinal polyposis and device assisted enteroscopy: where do we stand?
    Losurdo G; Di Leo M; Rizzi S; Lacavalla I; Celiberto F; Iannone A; Rendina M; Ierardi E; Iabichino G; De Luca L; Di Leo A
    Expert Rev Gastroenterol Hepatol; 2023; 17(8):811-816. PubMed ID: 37515779
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P.
    Ai YL; Wang WJ; Liu FJ; Fang W; Chen HZ; Wu LZ; Hong X; Zhu Y; Zhang CX; Liu LY; Hong WB; Zhou B; Chen QT; Wu Q
    Cell Res; 2023 Dec; 33(12):904-922. PubMed ID: 37460805
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.
    Yen CC; Yeh YM; Huang HY; Ting YL; Fu PA; Lin TC; Liu IT; Yen CJ
    Target Oncol; 2023 Jul; 18(4):611-623. PubMed ID: 37347391
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor loss-of-function mutations in stk11/lkb1 induce cachexia.
    Iyengar P; Gandhi AY; Granados J; Guo T; Gupta A; Yu J; Llano EM; Zhang F; Gao A; Kandathil A; Williams D; Gao B; Girard L; Malladi VS; Shelton JM; Evers BM; Hannan R; Ahn C; Minna JD; Infante RE
    JCI Insight; 2023 Apr; 8(8):. PubMed ID: 37092555
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Survival, surveillance, and genetics in patients with Peutz-Jeghers syndrome: A nationwide study.
    Jelsig AM; van Overeem Hansen T; Gede LB; Qvist N; Christensen LL; Lautrup CK; Frederiksen JH; Sunde L; Ousager LB; Ljungmann K; Bertelsen B; Karstensen JG
    Clin Genet; 2023 Jul; 104(1):81-89. PubMed ID: 37017260
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genetic Predisposition to colorectal cancer: How Many and Which Genes to Test?
    Rebuzzi F; Ulivi P; Tedaldi G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768460
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Strong Hereditary Predispositions to colorectal cancer.
    Hryhorowicz S; Kaczmarek-Ryś M; Lis-Tanaś E; Porowski J; Szuman M; Grot N; Kryszczyńska A; Paszkowski J; Banasiewicz T; Pławski A
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553592
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: results from the EPoS trials.
    Juul FE; Garborg K; Nesbakken E; Løberg M; Wieszczy P; Cubiella J; Kalager M; Kaminski MF; Erichsen R; Adami HO; Ferlitsch M; Furholm SKB; Zauber AG; Quintero E; Bugajski M; Holme Ø; Dekker E; Jover R; Bretthauer M
    Gut; 2023 May; 72(5):951-957. PubMed ID: 36307178
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Whole Genome Sequencing Applied in Familial Hamartomatous Polyposis Identifies Novel Structural Variations.
    Kariv R; Dahary D; Yaron Y; Petel-Galil Y; Malcov M; Rosner G
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011318
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PTEN and lkb1 are differentially required in Gli1-expressing mesenchymal cells to suppress gastrointestinal polyposis.
    Cotton JL; Dang K; Hu L; Sun Y; Singh A; Rajurkar MS; Li Q; Wu X; Mao J
    Cell Rep; 2022 Jul; 40(3):111125. PubMed ID: 35858546
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnosis and Management of cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on colorectal cancer.
    Boland CR; Idos GE; Durno C; Giardiello FM; Anderson JC; Burke CA; Dominitz JA; Gross S; Gupta S; Jacobson BC; Patel SG; Shaukat A; Syngal S; Robertson DJ
    Gastroenterology; 2022 Jun; 162(7):2063-2085. PubMed ID: 35487791
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the U.S. Multi-Society Task Force on colorectal cancer.
    Boland CR; Idos GE; Durno C; Giardiello FM; Anderson JC; Burke CA; Dominitz JA; Gross S; Gupta S; Jacobson BC; Patel SG; Shaukat A; Syngal S; Robertson DJ
    Gastrointest Endosc; 2022 Jun; 95(6):1025-1047. PubMed ID: 35487765
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Diagnosis and Management of cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on colorectal cancer.
    Boland CR; Idos GE; Durno C; Giardiello FM; Anderson JC; Burke CA; Dominitz JA; Gross S; Gupta S; Jacobson BC; Patel SG; Shaukat A; Syngal S; Robertson DJ
    Am J Gastroenterol; 2022 Jun; 117(6):846-864. PubMed ID: 35471415
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Landscape of
    Salem ME; El-Refai SM; Sha W; Puccini A; Grothey A; George TJ; Hwang JJ; O'Neil B; Barrett AS; Kadakia KC; Musselwhite LW; Raghavan D; Van Cutsem E; Tabernero J; Tie J
    JCO Precis Oncol; 2022 Mar; 6():e2100245. PubMed ID: 35319967
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pancreatic cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
    Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.